Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Psychopharmacology of HIV-Related Psychiatric Disorders

  • Chapter
The Practitioner’s Guide to Psychoactive Drugs

  • 134 Accesses

Abstract

Over the last 15 years, the annual number of reported cases of the acquired immunodeficiency syndrome (AIDS) in the United States has risen steadily. According to the 1995 year-end edition of the HIV/AIDS Surveillance Report issued by the Centers for Disease Control (CDC), a total of 513,486 cases of adult and pediatric AIDS were diagnosed in the United States between 1980 and 1995. Approximately 60% of these individuals have died. In fact, we have witnessed this infection and its related disorders becoming the leading cause of death in adults aged 25 to 44 years, only midway through the second decade of the human immunodeficiency virus (HTV)/AIDS pandemic.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams F.: Neuropsychiatric evaluation and treatment of delirium in the critically ill cancer patient. Cancer Bull 36(3): 156–160, 1984.

    Google Scholar 

  2. Adle-Biassette H., Colombel L. M., Poron F., et al: Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol 21: 218–227, 1995.

    Article  PubMed  CAS  Google Scholar 

  3. Alberts G. W., Saenz R. E., Moses J. A.: Tolerability of oral dextromethorphan in patients with a history of brain ischemia. Clin Neuropharmacol 15: 509–514, 1992.

    Article  Google Scholar 

  4. American Academy of Neurology: Working Group of the AAN and AIDS Task Force. Nomenclature and research definition for neurologic manifestations of HIV-l infection. Neurology 41: 778–785, 1991.

    Article  Google Scholar 

  5. Atkinson J. H., Grant I., Kennedy C. J., et al: Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. Arch Gen Psychiatry 45: 859–864, 1988.

    Article  PubMed  Google Scholar 

  6. Aylward E. H., Brettschneider P. D., McArthur J. C., et al: Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152: 987–994, 1995.

    PubMed  CAS  Google Scholar 

  7. Beason-Hazen S., Nasrallah H. A., Bornstein R. A.: Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. J Neuropsychiatry Clin Neurosci 6: 43–49, 1994.

    PubMed  CAS  Google Scholar 

  8. Becker J. T., Caldrarao R., Lopez O. L., Dew M. A., Dorst S. K., Banks G.: Qualitative features of the memory deficit associated with HIV infection and AIDS: Cross-validation of a discriminant function classification scheme. J Clin Exp Neuropsychol 17: 134–142, 1995.

    Article  PubMed  CAS  Google Scholar 

  9. Berger J. R., Kaszovitz B., Post M. J., et al: Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med 107: 78–87, 1987.

    PubMed  CAS  Google Scholar 

  10. Blaney N. T., Goodkin K., Morgan R. O., et al: A stress moderator model in early HIV-l infection: Concurrent analysis of life events, hardiness, and social support. J Psychosom Res 35: 297–305, 1991.

    Article  PubMed  CAS  Google Scholar 

  11. Bolan G.: Management of syphilis in HIV-infected persons, in Sande M. A., Volberding P. A. (eds): The Medical Management of AIDS, 4th ed. Philadelphia, Saunders, 1995, pp 537–554.

    Google Scholar 

  12. Bornstein R. A., Nasrallah H. A., Para M. F., Whitacre C. C., Rosenberger P., Fass R. J.: Neuropsycho-logical performance in symptomatic and asymptomatic HIV infection. Acquired Immune Defic Syndr 7: 519–524, 1993.

    CAS  Google Scholar 

  13. Bredesen D. E., Levy R. M., Rosenblum M. L.: The neurology of human immunodeficiency virus infection. Q J Med 68: 665–667, 1988.

    PubMed  CAS  Google Scholar 

  14. Breitbart W., Marotta R., Platt M., et al: A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153: 231–237, 1996.

    PubMed  CAS  Google Scholar 

  15. Brew B. J.: Central and peripheral nervous system abnormalities. Med Clin North Am 76(1): 63–81, 1992.

    Google Scholar 

  16. Bridge T. P., Haseltine P. M. R., Parker E. S.: Initial pahse I testing of Peptide-T in AIDS patients and normal controls. Lancet 1: 226, 1989.

    Google Scholar 

  17. Brouillette M. J., Chouinard G., Lalonde R.: Didanosine-induced mania in HIV infection. Am J Psychiatry 151: 1839–1840, 1994.

    PubMed  CAS  Google Scholar 

  18. Brown J. H., Henteleff P., Barakat S., et al: Is it normal for terminally ill patients to desire death. Am J Psychiatry 143: 208–211, 1986.

    PubMed  CAS  Google Scholar 

  19. Cavanaugh S., Clark D. C., Gibbons R. D.: Diagnosing depression in the hospitalized medically ill. Psychosomatics 24: 809–815, 1983.

    Article  PubMed  CAS  Google Scholar 

  20. Centers for Disease Control: 1993revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 41(44-17): 1–19, 1992.

    Google Scholar 

  21. Codazzi F., Menegon A., Zacchetti D., et al: HIV-l gpl20 glycoprotein induces (Ca2+)i responses not only in type-2 but also type-l astrocytes and oligodendrocytes of the rat cerebellum. Eur J Neurosci 7: 1333–1341, 1995.

    Article  PubMed  CAS  Google Scholar 

  22. Drew W. L., Buhles W., Erlich K. S.: Management of herpes virus infection (CMV, HSV, VZV), in Sande M. A., Volberding P. A. (eds): The Medical Management of AIDS. 4th ed. Philadelphia, W. B. Saunders, 1995, pp 512–536.

    Google Scholar 

  23. Dreyer E. B., Kaiser P. K., Offermann J. T.: HIV-l coat protein neurotoxicity prevented by calcium channel antagonists. Science 248: 364–367, 1990.

    Article  PubMed  CAS  Google Scholar 

  24. Anon: Drugs that cause psychiatric symptoms. The Medical Letter 35: 901, 1993.

    Google Scholar 

  25. Empfield M., Cournos F., Meyer I., et al: HIV seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am J Psychiatry 150: 47–52, 1993.

    PubMed  CAS  Google Scholar 

  26. Falangola M. F., Hanly A., Galvao-Castro B., Petito C. K.: HIV infection of human choroid plexus: A possible mechanism of viral entry into the CNS. J Neuropathol Exp Neurol 54: 497–503, 1995.

    Article  PubMed  CAS  Google Scholar 

  27. Fernandez D., Holmes V. F., Levy J. K., Ruiz P.: Consultation-liaison psychiatry and HIV-related disorders. Hosp Community Psychiatry 40: 146–153, 1989.

    PubMed  CAS  Google Scholar 

  28. Fernandez F., Levy J. K.: Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 291(1)38–46, 1988.

    Google Scholar 

  29. Fernandez F., Levy J. K.: The use of molindone in the treatment of psychotic and delirious patients infected with the human immunodeficiency virus: Case reports. Gen Hosp Psychiatry 15: 31–35, 1993.

    Article  PubMed  CAS  Google Scholar 

  30. Fernandez F., Levy J. K.: Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection. Psychiatry Med 9(3): 377–394, 1991.

    Google Scholar 

  31. Fishman B., Perry S., Jacobsberg L., et al: Psychological factors predicting distress after HIV testing. Abstracts of the World Health Organization Fifth International Conference on AIDS, Montreal, Canada. World Health Organizatin, 1989, p 737.

    Google Scholar 

  32. Goethe K. E., Mitchell J. E., Marshall D. W., et al: Neuropsychological and neurological function of human immunodeficiency virus seropositive asymptomatic individuals. Arch Neurol 46: 129–133, 1989.

    Article  PubMed  CAS  Google Scholar 

  33. Grant I., Atkinson J. H., Hesselink J. R., Kennedy C. J., Richman D. D., Spector S. A., McCutchan J. A.: Evidence for early centran nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychological testing and magnetic resonance imaging. Ann Int Med 107: 828–836, 1987.

    PubMed  CAS  Google Scholar 

  34. Gyorkey F., Melnick J. L., Gyorkey P.: Human immunodeficiency virus in brain biopsies of patients with AIDS and progressive encephalopathy. J Infect Dis 155: 870–876, 1987.

    Article  PubMed  CAS  Google Scholar 

  35. Hill J. M., Farrar W. L., Pert C. B.: Autoradiographic localization of T4 antigen, the HIV receptor in human brain. Int J Neurosci 32: 687–693, 1987.

    Article  PubMed  CAS  Google Scholar 

  36. Holmes V. F., Fricchione G. L.: Hypomania in an AIDS patient receiving amitriptyline for neuropathic pain. Neurology 39: 305, 1989.

    Google Scholar 

  37. Jacobsberg L., Frances A., Perry S.: Axis II diagnosis among volunteers for HIV testing and counseling. Am J Psychiatry 152: 1222–1224, 1995.

    PubMed  CAS  Google Scholar 

  38. Lipton S. A.: Menāntine prevents HIV coat protein-induced neuronal injury in vitro. Neurology 42: 1403–1405, 1992.

    Article  PubMed  CAS  Google Scholar 

  39. Lyketsos C. G., Hanson A. L., Fishman M., Rosenblatt A., McHugh P. R., Treisman G. J.: Manic syndrome early and late in the course of HIV. Am J Psychiatry 150: 326–327, 1993.

    PubMed  CAS  Google Scholar 

  40. Maldonado J. L., Fernandez J., Fernandez F.: Depresión en el paciente con enfermedades médicas. Medico Interamericano 1: 353–357, 1996.

    Google Scholar 

  41. Martin J. L.: Psychological consequences of AIDS-related bereavement among gay men. J Consult Clin Psychol 56: 856–862, 1988.

    Article  PubMed  CAS  Google Scholar 

  42. Martin J. L., Dean L.: Effects of AIDS-related and HIV-related illness on psychological distress among gay men: A 7-year longitudinal study, 1985-1991. J Consult Clin Psychol 61: 94–103, 1993.

    Article  PubMed  CAS  Google Scholar 

  43. Marzuk P. M., Tierney H., Tardiff K.: Increased risk of suicide with AIDS. JAMA 259: 1333–1337, 1988.

    Article  PubMed  CAS  Google Scholar 

  44. Maxwell S., Scheftner W. A., Kessler H. A., Busch K.: Manic syndrome associated with zidovudine treatment. JAMA 259: 3406–3407, 1988.

    Article  PubMed  CAS  Google Scholar 

  45. McKegney F. P., O’Dowd M. A.: Suicidal ideation and HIV status. Am J Psychiatry 149: 396–398, 1992.

    PubMed  CAS  Google Scholar 

  46. Meyer I., Empfield M., Engel D., Cournos F.: Characteristics of HIV-positive chronically mentally ill inpatients. Psychiatr O 66: 201–207, 1995.

    CAS  Google Scholar 

  47. Nath A., Padua R. A., Geiger J. D.: HIV-l coat protein gp120-induced increases in levels of intrasynaptosomal calcium. Brain Res 678: 200–206, 1995.

    Article  PubMed  CAS  Google Scholar 

  48. Nichols S. E.: Psychosocial reactions of persons with the acquired immunodeficiency syndrome. Ann Intern Med 103: 765–767, 1985.

    PubMed  CAS  Google Scholar 

  49. Nichols S. E.: Psychiatric aspects of AIDS. Psychosomatics 24: 1083–1089, 1983.

    Article  PubMed  Google Scholar 

  50. O’Dowd M. A., McKegney F. P.: Manic syndrome associated with zidovudine. JAMA 260: 3587–3588, 1988.

    Article  Google Scholar 

  51. Ostrow D., Grant I., Atkinson H.: Assessment and management of the AIDS patient with Neuropsychiatric disturbances. J Clin Psychiatry 49(Suppl): 14–22, 1988.

    Google Scholar 

  52. Perry S., Jacobsberg L. B., Fishman B., Frances A., Bobo J., Jacobsberg B. K.: Psychiatric diagnosis before serological testing for the human immunodeficiency virus. Am J Psychiatry 147: 89–93, 1990.

    PubMed  CAS  Google Scholar 

  53. Perry S. W.: Organic mental disorders caused by HIV: Update on early diagnosis and treatment. Am J Psychiatry 147: 696–710, 1990.

    PubMed  CAS  Google Scholar 

  54. Perry S. W., Tross S.: Psychiatric problems of AIDS inpatients in the New York Hospital: Preliminary report. Public Health Rep 99: 200–205, 1984.

    PubMed  CAS  Google Scholar 

  55. Pert C. B., Smith C. C., Ruff M. R., Hill J. M.: AIDS and its dementia as a neuropeptide disorder: Role of VIP receptor blockade by human immunodeficiency virus envelop. Ann Neurol 23(Suppl): S71–S73, 1988.

    Article  PubMed  CAS  Google Scholar 

  56. Peters S., Koh J., Choi D. W.: Zinc selectively blocks the action of Af-methyl-D-aspartate on cortical neurons. Science 236: 589–593, 1994.

    Article  Google Scholar 

  57. Podraza A. M., Bornstein R. A., Whitacre C. C., et al: Neuropsychological performance and CD4 levels in HIV-l asymptomatic infection. J Clin Exp Neuropsychol 16: 777–783, 1994.

    Article  PubMed  CAS  Google Scholar 

  58. Price R. W., Sidtis J. J., Navia B. H., Pumarola-Sune T., Ornitz D. B.: The AIDS dementia complex, in Rosenblum M. L., Levy R. M., Bredesen D. E. (eds): AIDS and the Nervous System. New York, Raven Press, 1988, pp 203–220.

    Google Scholar 

  59. Price R. W., Worley J. M.: Management of neurologic complications of HIV-l infection and AIDS, in Sande M. A., Volberding P. A. (eds): The Medical Management of AIDS 4th ed. Philadelphia, W.B.Saunders, 1995, pp 261–288.

    Google Scholar 

  60. Riccio M., Pugh K., Jadresic D., et al: Neuropsychiatric aspects of HIV-l infection in gay men: Controlled investigation of psychiatrie, enuropsychological and neurological status. J Psychosom Res 37: 819–830, 1993.

    Article  PubMed  CAS  Google Scholar 

  61. Rundell J. R., Kyle K. M., Brown G. R., Thomason J. L.: Risk factors for suicide attempts in a human immunodeficiency virus screening program. Psychosomatics 33: 24–27, 1992.

    Article  PubMed  CAS  Google Scholar 

  62. Saag M. S.: Cryptococcosis and other fungal infections (histoplasmosis, coccidiodomycosis), in Sande M. A., Volberding P. A. (eds): The Medical Management of AIDS. 4th ed. Philadelphia, W. B. Saunders. 1995, pp 437–459.

    Google Scholar 

  63. Schmitt F. A., Bigley J. W., and McKinnis R., et al: Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS related complex. N Engl J Med 319: 1573–1578, 1988.

    Article  PubMed  CAS  Google Scholar 

  64. Seines O. A., Miller E. N., McArthur J. C., Gordon B., Munoz A., Sheridan K., Fox R., Saah A. J.: Multicenter AIDS cohort study. HIV-l infection: No evidence of cognitive decline during the asymptomatic stages. Neurology 40: 204–208, 1990.

    Article  Google Scholar 

  65. Seines O. A., Miller E. N.: Development of a screening battery for HIV-related cognitive impairment: The MACS experience, in Grant I., Martin A. (eds): Neuropsychology of HIV Infection. New York, Oxford University Press, 1994, pp 176–185.

    Google Scholar 

  66. Siegel K.: Psychosocial aspects of rational suicide. Am J Psychother 3: 405–418, 1986.

    Google Scholar 

  67. Stern R. A., Silva S. G., Chaisson N., Evans D. L.: Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-l infection. Arch Neurol 53: 148–153, 1996.

    Article  PubMed  CAS  Google Scholar 

  68. Ushijima H., Nishio O., Klocking R., et al: Exposure to gp 120 of HIV-l induces an increased release of arachidonic acid in rat primary neuronal cell culture followed by NMDA receptor-mediated neurotoxicity. Eur J Neurosci 7: 1353–1359, 1995.

    Article  PubMed  CAS  Google Scholar 

  69. Van Gorp W. G., Miller E., Satz P., Visscher B.: Neuropsychological performance in HIV-l immunocompromised patients. J Clin Exp Neuropsychol 11: 35, 1989.

    Google Scholar 

  70. Wang F., Vittinghoff E., Malani H., Reingold A., Lewis E., Giordano J., Jannsen R.: Incidence, proportion of, and risk factors for AIDS patients diagnosed with HIV dementia. J AIDS Hum Retrovirol 8: 75–82, 1995.

    CAS  Google Scholar 

  71. Wesley A. L., Gatchel R. J., Polatin P. B., Kinney R. K., Mayer T. G.: Differentiation between somatic and cognitive/affective components of depression in commonly used measurements of depression in patients with chronic low-back pain. Let’s not mix apples and oranges. Spine 16(Suppl): S213-S215, 1991.

    Google Scholar 

  72. Wiley C. A., Masliah E., Morey M., et al: Neocortical damage during HIV infection. Ann Neurol 29: 651–657, 1991.

    Article  PubMed  CAS  Google Scholar 

  73. Wilkie F., Eisdorfer C., Morgan R., Loewenstein D. A., Szapocznik J.: Cognition in early human immunodeficiency virus infection. Arch Neurol 47: 433–440, 1990.

    Article  PubMed  CAS  Google Scholar 

  74. Wilkie F. L., Morgan R., Fletcher M. A. et al: Cognition and immune function in HIV-l infection. Acquired Immune Defic Syndr 6: 977–981, 1992.

    CAS  Google Scholar 

  75. Williams J. B. W., Rabkin J. G., Remien R. H., Gorman J. M.: Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection: II Standardized clinical assessment and lifetime psychopathology. Arch Gen Psychiatry 48: 124–130, 1991.

    Article  PubMed  CAS  Google Scholar 

  76. Yarchoan R., Berg G., Brouwers P., et al: Response of human immunodeficiency virus associated neurological disease to 3′-azido-3′-deoxythymidine. Lancet 1: 132–135, 1987.

    Article  PubMed  CAS  Google Scholar 

  77. Zhang J., Dawson V. L., Dawson T. M., Synder S. H.: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687–689, 1994.

    Article  PubMed  CAS  Google Scholar 

  78. Mellors J. W., Kingsley L. A., Rinaldo C. R. et al: Quantitation of HIV-l RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122: 573–579, 1995.

    PubMed  CAS  Google Scholar 

  79. Volberding P. A.: HIV quantification: clinical applications. Lancet 347: 71–72, 1996.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Jorge Maldonado M.D.

    Present address: Baylor College of Medicine, Houston, Texas, 77030, USA

Authors and Affiliations

  1. Department of Psychiatry, Stritch School of Medicine, Loyola University Medical Center, Maywood, Illinois, 60153, USA

    Francisco Fernandez M.D.

  2. Psychosomatic Medicine and Consultation Liaison Psychiatry, St. Luke’s Episcopal Hospital, Houston, Texas, 77030, USA

    Jorge Maldonado M.D.

Authors
  1. Francisco Fernandez M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jorge Maldonado M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Arizona College of Medicine, Tucson, Arizona, USA

    Alan J. Gelenberg M.D.

  2. The Better Homes Fund, Newton Centre, Massachusetts and Harvard Medical School, Boston, Massachusetts, USA

    Ellen L. Bassuk M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fernandez, F., Maldonado, J. (1998). Psychopharmacology of HIV-Related Psychiatric Disorders. In: Gelenberg, A.J., Bassuk, E.L. (eds) The Practitioner’s Guide to Psychoactive Drugs. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5877-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-5877-4_11

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7695-8

  • Online ISBN: 978-1-4615-5877-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation